Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Angiodynamics (ANGO) over the last 11 years, with Q4 2025 value amounting to -$102000.0.

  • Angiodynamics' Interest & Investment Income fell 14358.97% to -$102000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $32000.0, marking a year-over-year decrease of 9822.32%. This contributed to the annual value of $978000.0 for FY2025, which is 3940.52% down from last year.
  • Per Angiodynamics' latest filing, its Interest & Investment Income stood at -$102000.0 for Q4 2025, which was down 14358.97% from -$4000.0 recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Interest & Investment Income registered a high of $606000.0 during Q3 2024, and its lowest value of -$102000.0 during Q4 2025.
  • Over the past 3 years, Angiodynamics' median Interest & Investment Income value was $184500.0 (recorded in 2024), while the average stood at $248600.0.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first soared by 40924.37% in 2024, then plummeted by 14358.97% in 2025.
  • Quarter analysis of 3 years shows Angiodynamics' Interest & Investment Income stood at $534000.0 in 2023, then crashed by 56.18% to $234000.0 in 2024, then crashed by 143.59% to -$102000.0 in 2025.
  • Its Interest & Investment Income stands at -$102000.0 for Q4 2025, versus -$4000.0 for Q3 2025 and $3000.0 for Q2 2025.